29.10.2018 - 31.10.2018The Colonnade Boston Hotel, 120 Huntington Avenue, 02116 Boston, USA
08:00 to 13:00
Conference themes Neuromuscular diseases are a huge unmet clinical need, with huge advances and excitement in the field now is the time combine forces and help accelerate development of truly curative neuromuscular therapeutics.
The inaugural Neuromuscular Drug Development Summit is industry's first dedicated discussion and networking forum focused on bringing together neuromuscular thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing.
Professional congress organizer (PCO) Neuromuscular Drug Development Summit
Speakers: Greg La Rosa Chief Scientific Officer, Senior Vice President, Rare Disease Research and Development Pfizer, Brian Kaspar Chief Scientific Officer Avexis, and more.